The first patient visit has taken place for the SURMOUNT-REAL UK clinical trial of Eli Lilly and Company’s weight-loss drug, tirzepatide.

Several 3D printing technologies are currently considered more clinically applicable, including SSE, fused deposition ...

Gain leadership and innovation insights from CEO of the Year finalist at 2025 CPHI Pharma Awards, Mahler Hanns-Christian, who ...

The CNPV pilot program significantly reduces review times, but may challenge safety standards and resource allocation.

In particular, Konagurthu says, AI/ML can help sift through a field of drug candidates in which the percentage that are ...

With big moves and investments being made via pharma outsourcing, it’s important for industry professionals to stay on top of trends and innovations.

Artificial intelligence (AI) and machine learning (ML) tools offer an ultra-material-sparing approach to accelerate ...

To meet rising demand, developers of precision radiopharmaceutical therapies must overcome challenges in global isotope ...

When we do things like quantum calculations, we look at the confirmer space. So what that does is give us insight into how a ...

The emerging prevalence of digitalization is a key topic for manufacturers handling excipients. Digital transformation and ...

Unlock the potential of high-purity methylcellulose in biotech. Join our upcoming webinar to explore how METHONOVA™ enhances ...

In September 2025, the European Commission (EC), together with the Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA), revealed two new goals for clinical trials to ensure ...